CPhI North America to Expand Presence and Focus in 2018
December 14, 2017
CPhI North America, the only event to bring the complete North American pharma supply chain together, today announced the opening of 2018 event registration. CPhI North America will take place April 24-26, 2018 at the Pennsylvania Convention Center in Philadelphia.
It will feature an expanded show footprint ideal for networking, sourcing, education and innovation in drug development and manufacturing.
Two new zones including a Bioprocessing Zone and the P-MEC Zone, a machinery zone to promote the latest technology in manufacturing equipment, will join legacy zones, InformEx, iCSE, FDF, InnoPack and CPhI.
Attendance at the event is expected to surpass 2017 levels, which attracted more than 7,400 pharmaceutical industry professionals and thought leaders and more than 630 exhibitors.
Attendees are urged to register and secure booth space early. Registration for CPhI North America is now open at: www.CPhINorthAmerica.com/register.
"The event's inaugural success underscores the connective power of CPhI," said Joseph Marks, Brand Director for CPhI North America.
He added, "The US pharmaceutical and fine chemical industry is dynamic, and filled with regulatory and legislative uncertainties. CPhI North America provides show-goers an engaging and focused environment, helping them overcome today's hurdles while also preparing for the challenges of tomorrow."
The exhibitor floor has strategically been designed to include the following seven zones:
- NEW! Bioprocessing: Bioprocessing zone will provide greater access and pathway to opportunities in the next generation of pharmaceuticals.
- NEW! P-MEC: Machinery zone will showcase the latest pharmaceutical equipment, machinery and technology.
- InformEx: Specialty and fine chemicals zone will address innovative molecule development.
- CPhI: Manufacturing ingredients zone will support API and excipients
- iCSE: Drug development zone will highlight world-class CROs specializing in both pre-clinical and clinical research for drug development.
- FDF: Finished drug products zone will feature leading small and large molecule CDMO/CMOs.
- InnoPack: Packaging zone will showcase packaging innovation.
Alongside CPhI North America, CPhI CONNECT will have a full conference program designed to Foster Innovation in Drug Development and Manufacturing in a New Era of Regulation.
The CPhI CONNECT agenda will include discussions on pharmaceutical manufacturing, outsourcing, R&D, drug delivery and supply chain related topics for small and large molecule finished drugs. It has also been extended to focus on biopharmaceuticals, with a full day symposia and breakout sessions on trending topics such as biosimilars/biogenerics.
Other key content will address the following topics:
- Novel Drug Delivery Systems and Emerging Technologies
- R&D Innovation
- Regulatory Developments
- Continuous Manufacturing Advancements
- Process Development
- Tech Transfer
- Quality Metrics / Supply Chain Best Practices
- Bio-Manufacturing Opportunities and Challenges
More information about CPhI North America and CPhI CONNECT is available at https://CPhINorthAmerica.com.
Partner Voices
MGM Resorts is committed to fostering an inclusive and diverse culture, not just among employees and guests but also within its supply chain. The company prioritizes procuring goods and services from businesses owned by minorities, women, veterans, people with disabilities, LGBTQ individuals and those facing economic disadvantages. This commitment is integral to MGM Resorts' global procurement strategy.
Through its voluntary supplier diversity program, MGM Resorts actively identifies and connects certified diverse-owned suppliers to opportunities within its supply chain. The company is on track to spend at least 15% of its biddable procurement with diverse-owned businesses by 2025, demonstrating that supplier diversity is not only a social responsibility but also a strategic business imperative.
Supplier diversity isn’t just the right thing to do – it’s good for business. A diverse supply chain allows access to a broader range of perspectives and experience, helping to drive innovation, entrepreneurship and resilience, while strengthening communities. At MGM Resorts, engaging diverse suppliers ensures best-in-class experiences for guests and clients. Supplier diversity ensures a more resilient supply chain while supporting economic development in the communities in which it operates.
The impact of MGM Resorts' supplier diversity initiatives is significant. In 2023, these efforts supported over 3,500 jobs across more than 30 states, contributed over $214 million in income for diverse-owned businesses and generated more than $62 million in tax revenue. The story extends beyond the numbers – it reflects the tangible benefits brought to small and diverse-owned businesses, fostering economic empowerment in their communities.
MGM Resorts also supports the development and business skills of diverse-owned businesses through investment, mentorship and education. Through the MGM Resorts Supplier Diversity Mentorship Program, the company identifies, mentors and develops diverse-owned businesses to fill its future pipeline, while providing businesses with tools and resources to empower and uplift. Since 2017, the program has successfully graduated 105 diverse-owned businesses and is on track to achieve its goal of 150 graduates by 2025.
MGM Resorts’ commitment to supplier diversity not only enhances its business operations but also plays a crucial role in uplifting communities and fostering economic development. This approach reinforces the idea that diversity is a powerful driver of innovation and resilience, benefiting both the company and the wider community.
Add new comment